Ahmed Shahab, Eng Cathy
Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Colon Rectal Surg. 2017 Nov;30(5):383-386. doi: 10.1055/s-0037-1606372. Epub 2017 Nov 27.
Colorectal cancer is one of the major leading causes of death in both men and women. The successful management of colon or rectal cancer demands a multidisciplinary approach. In the last few years, significant improvement has been noticed in the management of localized rectal cancer to reduce local recurrence and obtain complete pathological response following appropriate surgical steps, if necessary. Implementation of neoadjuvant therapy not only enhances disease control, it may also ensure sphincter preserving procedures or organ-preserving options. This article principally concentrates on the current neoadjuvant treatment for locally advanced rectal cancer and the prognostic outcomes of such therapy, including a discussion on the historical perspective.
结直肠癌是男性和女性主要的致死原因之一。结肠癌或直肠癌的成功治疗需要多学科方法。在过去几年中,局部直肠癌的治疗有了显著改善,以减少局部复发,并在必要时通过适当的手术步骤获得完全的病理缓解。新辅助治疗的实施不仅能加强疾病控制,还可能确保保留括约肌的手术或保留器官的选择。本文主要关注局部晚期直肠癌的当前新辅助治疗及其预后结果,包括对历史观点的讨论。